Skip to main content
Clinical Trials/NCT03335020
NCT03335020
Withdrawn
Phase 1

Assessment of Contrast-enhanced Ultrasonography, Shear Wave Elastography, Strain Imaging, and 3-D Volume Ultrasonography on Arterial Wall Visualization and Stiffness in Patients With Fibromuscular Dysplasia...

Mayo Clinic1 site in 1 countryApril 1, 2018

Overview

Phase
Phase 1
Intervention
Shear Wave Elastography
Conditions
Fibromuscular Dysplasia of Arteries
Sponsor
Mayo Clinic
Locations
1
Primary Endpoint
Number of Subjects who Completed All of the Ultrasound Examinations
Status
Withdrawn
Last Updated
5 years ago

Overview

Brief Summary

The researchers are trying to see whether contrast-enhanced ultrasonography, shear wave elastography, strain imaging, and 3-D volume ultrasonography improves arterial wall visualization and identifies arterial elastic properties among individuals with fibromuscular dysplasia (FMD), atherosclerosis, personal history of spontaneous coronary artery dissections (SCAD), or personal history of segmental arterial mediolysis (SAM) that may be different compared to those without the aforementioned conditions.

Detailed Description

Aims, purpose, or objectives: 1. To describe whether contrast-enhanced ultrasonography, strain imaging, and 3-D volume ultrasonography are helpful to characterize affected arteries and improve the imaging of arterial wall among patients with Fibromuscular Dysplasia (FMD) and segmental arterial mediolysis (SAM). 2. Evaluate the arterial elastic properties of individuals with FMD and compare to normal individuals, those with atherosclerosis disease, those with personal history of spontaneous coronary artery dissections (SCAD), and/or personal history of segmental arterial mediolysis (SAM) by elastography. 3. Identification of vulnerable arterial elastic properties using contrast-enhanced ultrasonography, shear wave elastography, strain imaging, and 3-D volume ultrasonography to predict short-term and long-term outcomes among individuals with FMD, normal individuals, those with atherosclerosis disease, those with SCAD, and/or SAM. 4. Develop risk factor profiles and risk score systems of patients undergoing contrast-enhanced ultrasonography, shear wave elastography, strain imaging, and 3-D volume ultrasonography among individuals with FMD, those with atherosclerosis disease, those with personal history of SCAD, and/or personal history of SAM.

Registry
clinicaltrials.gov
Start Date
April 1, 2018
End Date
December 31, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Matthew W. Urban

Associate Professor of Biomedical Engineering

Mayo Clinic

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of fibromuscular dysplasia (FMD), and/or segmental arterial mediolysis (SAM), and/or spontaneous coronary artery dissection (SCAD), and those with atherosclerosis, and normal individuals.
  • Adult male and non-pregnant female patient 18-100 years of age.
  • Patients who are able and willing to sign the informed consent will be enrolled.

Exclusion Criteria

  • Missing records to determine whether or not they have fibromuscular dysplasia (FMD), and/or segmental arterial mediolysis (SAM), and/or spontaneous coronary artery dissection (SCAD), and those with atherosclerosis, and normal individuals.
  • Patients who do not accept to participate in research studies.
  • Prior contraindication to contrast agent.
  • Women who are breastfeeding or pregnant
  • Patients less than 18 yo

Arms & Interventions

Normal

Healthy volunteers. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

Intervention: Shear Wave Elastography

Normal

Healthy volunteers. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

Intervention: Pulse Wave Imaging

Normal

Healthy volunteers. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

Intervention: Contrast-Enhanced Ultrasound

Normal

Healthy volunteers. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

Intervention: Strain Imaging

Normal

Healthy volunteers. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

Intervention: 3-D Volume Ultrasound

Fibromuscular Dysplasia (FMD)

Subjects with diagnosis of FMD. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

Intervention: Shear Wave Elastography

Fibromuscular Dysplasia (FMD)

Subjects with diagnosis of FMD. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

Intervention: Pulse Wave Imaging

Fibromuscular Dysplasia (FMD)

Subjects with diagnosis of FMD. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

Intervention: Contrast-Enhanced Ultrasound

Fibromuscular Dysplasia (FMD)

Subjects with diagnosis of FMD. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

Intervention: Strain Imaging

Fibromuscular Dysplasia (FMD)

Subjects with diagnosis of FMD. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

Intervention: 3-D Volume Ultrasound

Atherosclerosis

Subjects with diagnosis of atherosclerosis. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

Intervention: Shear Wave Elastography

Atherosclerosis

Subjects with diagnosis of atherosclerosis. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

Intervention: Pulse Wave Imaging

Atherosclerosis

Subjects with diagnosis of atherosclerosis. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

Intervention: Contrast-Enhanced Ultrasound

Atherosclerosis

Subjects with diagnosis of atherosclerosis. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

Intervention: Strain Imaging

Atherosclerosis

Subjects with diagnosis of atherosclerosis. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

Intervention: 3-D Volume Ultrasound

Spontaneous Coronary Artery Dissection (SCAD)

Subjects with diagnosis of SCAD. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

Intervention: Shear Wave Elastography

Spontaneous Coronary Artery Dissection (SCAD)

Subjects with diagnosis of SCAD. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

Intervention: Pulse Wave Imaging

Spontaneous Coronary Artery Dissection (SCAD)

Subjects with diagnosis of SCAD. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

Intervention: Contrast-Enhanced Ultrasound

Spontaneous Coronary Artery Dissection (SCAD)

Subjects with diagnosis of SCAD. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

Intervention: Strain Imaging

Spontaneous Coronary Artery Dissection (SCAD)

Subjects with diagnosis of SCAD. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

Intervention: 3-D Volume Ultrasound

Segmental Arterial Mediolysis (SAM)

Subjects with diagnosis of SAM. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

Intervention: Shear Wave Elastography

Segmental Arterial Mediolysis (SAM)

Subjects with diagnosis of SAM. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

Intervention: Pulse Wave Imaging

Segmental Arterial Mediolysis (SAM)

Subjects with diagnosis of SAM. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

Intervention: Contrast-Enhanced Ultrasound

Segmental Arterial Mediolysis (SAM)

Subjects with diagnosis of SAM. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

Intervention: Strain Imaging

Segmental Arterial Mediolysis (SAM)

Subjects with diagnosis of SAM. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

Intervention: 3-D Volume Ultrasound

Outcomes

Primary Outcomes

Number of Subjects who Completed All of the Ultrasound Examinations

Time Frame: 2 years after starting enrollment

Completion of ultrasound examinations to determine visualization of arterial wall (contrast-enhanced ultrasound, 3-D volume ultrasound) and its mechanical properties (shear wave elastography, pulse wave imaging, strain imaging)

Study Sites (1)

Loading locations...

Similar Trials